How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? – A Statistical Analysis of the ClinicalTrials.gov Database
POLS: July 15, 2014 Background Achieving transparency in clinical trials, through either publishing results in a journal or posting results to the ClinicalTrials.gov (CTG) web site, is an essential public health good. However, it remains unknown what proportion of completed studies achieve public disclosure of results (PDOR), or what factors explain these differences. Methods We analyzed […]
It Will Never Feel Like Enough, But Participating in Research Helps
Michaeljfox: July 15, 2014 I used to think that the feeling that I wasn’t doing enough in the fight against Parkinson’s disease was just a neurosis of mine. As the daughter of a person with Parkinson’s, I help my dad with his annual golf tournament. I write for The Michael J. Fox Foundation’s FoxFeed blog, […]
More Than Meets the IRB: Conversation with Molly Tovar and Pete Coser
Wustl.edu: (7/2014) In this seventh installment of “More Than Meets the IRB,” Molly Tovar (PhD, Director of the Kathryn M. Buder Center for American Indian Studies) and Peter Coser, Jr. (MHR), talk with us about ethical and cultural issues related to American Indian and Alaska Native (AIAN) research. Our guests for this podcast have extensive […]
Where’s the evidence for how we run clinical trials?
Blogs.biomedcentral: July 15, 2014 No one ever said that doing a clinical trial was easy. Indeed it often feels like a Sisyphean task, when faced with obdurate funding committees, or centres that seem unable to recruit a single patient, when just six months previously they were inundated with them. Every piece of research has its […]
Sources of Racial/Ethnic Differences in Awareness of HIV Vaccine Trials
Ajph: Jan 16, 2014 Michael P. Arnold, Michele Andrasik, Shelly Karuna, and Steven Wakefield are with the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA. Stewart Landers is with Boston Health Services, John Snow Inc., Boston, MA. Matthew J. Mimiaga is with the Department of Epidemiology, Harvard School of Public Health, […]
21st Century Cures: Modernizing Clinical Trials
July 9, 2014 Advances in Technology and Personalized Medicine Can Help Bring Drugs and Devices to Patients More Efficiently WASHINGTON, DC – The Energy and Commerce Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), today held a hearing in the 21st Century Cures initiative to discuss opportunities to modernize clinical trials in the effort to […]
A Blueprint for Helping Children with Rare Diseases
FDA BLOG: July 8, 2014 Editor’s Note: This blog has been updated to provide additional information about our use of expedited programs to speed rare disease medical product development. The U.S. Congress and the Food and Drug Administration have long focused on bringing new therapies to patients with rare diseases, including children. Two years […]
